Massive study sheds light on liver surgery for rare cancers
NCT ID NCT07180641
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This completed study looked back at over 1,000 patients who had liver surgery for cancers that started elsewhere in the body (not colorectal). Researchers tracked survival and complications to learn what works best. The goal is to create better treatment recommendations for these complex cases.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this registry could provide clearer guidelines for treating liver metastases from cancers other than colorectal cancer.
- What could go wrong
- This is an observational study, not a trial of a new treatment. It cannot prove what works best, only describe past outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATECTOMY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A new test could reveal how radiation affects the liver
- A new clue in the fight against colorectal cancer recurrence?
- Which nerve block gets you breathing easier after liver surgery?
- A new way to read CT scans may predict which liver surgery patients will develop Life-Threatening failure
- Could a two-vein embolization trick turn inoperable liver tumors into operable ones?
- New ultrasound technique could reveal hidden blood vessels in liver tumors